Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban—A European comparative drug utilization study

Despite a tremendous increase of direct oral anticoagulants (DOACs) prescriptions in recent years, only few data is available analysing prescribers' adherence to Summary of Product Characteristics (SmPC). We aimed to assess adherence to registered indications, contraindications, special warning...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Basic & clinical pharmacology & toxicology 2021-03, Vol.128 (3), p.440-454
Hauptverfasser:	Rottenkolber, Marietta, Schmiedl, Sven, Ibánez, Luisa, Sabaté, Mònica, Ballarín, Elena, Vidal, Xavier, Leon‐Muñoz, Luz María, Huerta, Consuelo, Martin Merino, Elisa, Montero, Dolores, Gasse, Christiane, Andersen, Morten, Aakjær, Mia, De Bruin, Marie Louise, Gerlach, Roman, Tauscher, Martin, Souverein, Patrick C., Ham, Rianne, Klungel, Olaf, Gardarsdottir, Helga
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Contraindications direct oral anticoagulant Drug interaction Drug interactions drug utilization Fibrillation Inflammation pharmacoepidemiology SmPC adherence
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!